NEW YORK, June 25 - IBM and Spotfire said Monday they would work together to combine Spotfire's software with IBM's back-end information management, data integration, and computing infrastructure. 

The companies also said that Aventis would be the first customer to use this combination of Spotfire's DecisionSite analysis platform and IBM's DiscoveryLink integration middleware. 

Financial terms for the partnerships were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.